CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors

By GlobeNewswire

SAN DIEGO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a national shareholder rights law firm with an office in Denver, Colorado, has begun investigating potential securities claims on behalf of Biodesix, Inc. (NASDAQ: BDSX) investors following the Company's sharp stock decline on November 6, 2026. The investigation concerns whether Biodesix, a Louisville, Colorado-based diagnostic solutions company, or its officers made materially false or misleading statements or failed to disclose material information to investors.

What if I purchased Biodesix securities?

If you purchased Biodesix securities and suffered losses, contact Johnson Fistel to learn more about the investigation and your potential legal options. Individuals with information relevant to the investigation are also encouraged to contact the firm.

Visit our Biodesix investigation page: https://www.johnsonfistel.com/investigations/biodesix-inc/

You may also contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you.

What prompted the investigation?

On November 5, 2026, Biodesix reported third-quarter revenue of $24.0 million and reduced its full-year 2026 revenue guidance to $101 million to $103 million, down from its prior guidance of $108 million to $114 million. The Company attributed its disappointing growth in part to challenges involving its sales force, including staffing issues.

Following these disclosures, Biodesix shares declined more than 50% during intraday trading on November 6, 2026.

Who Is Johnson Fistel, PLLP?

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm's Colorado office is located in Denver. Johnson Fistel represents individual and institutional investors in shareholder derivative and securities class action lawsuits. The firm also represents foreign investors who have purchased securities on U.S. exchanges.

Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:

Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker | (619) 814-4471
jimb@johnsonfistel.com
https://www.johnsonfistel.com/


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.